Medical Oncologist. Head-Phase I Program, Oncology Institute of Southern Switzerland. Professor-Università della Svizzera Italiana.
Bellinzona, CH
Joined September 2017
- Tweets69
- Following150
- Followers133
- Likes385
Anastasios Stathis retweeted
MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO
sciencedirect.com/science/ar…
Anastasios Stathis retweeted
Great session this afternoon on #oncology #drug development 💉💊
#Biotech status & prospects
Fruitful live discussion & interaction
#ESMOTAT24 – at Paris, France
Anastasios Stathis retweeted
#ESMOTAT2023 starting. Amazing agenda and very excited to see so many attendees from all over the world in this important drug development meeting👏👏👏
Anastasios Stathis retweeted
ESMO announces Funda Meric-Bernstam as the recipient of 2024 TAT Honorary Award for her outstanding contributions to #PrecisionOncology.
📅 She will deliver her award lecture on 26 February at the #ESMOTAT24 in Paris
📌ow.ly/nTmE50QymhO.
Anastasios Stathis retweeted
#ESMOTAT24: Early registration deadline 📢⏲️ 10 January 2024 at 23:59 (CET). Watch @LSeymourMD, Shivaani Kummar, Irene Braña, Timothy Yap, @lillian_siu, @ElenaGarralda & @AnastasiosStat2 give their takes on why you should attend. 👇
ow.ly/8W3X50Qp5TU
Anastasios Stathis retweeted
#ESMOTAT24: Last few hours to make sure you are part of this international multi-stakeholder forum in the early drug development arena. ⏰Abstract submission deadline today (28/11, 21:00 CET)
ow.ly/PSnM50QbS8G
@lillian_siu @ElenaGarralda @AnastasiosStat2
Anastasios Stathis retweeted
#ESMOTAT24: Be part of this international multi-stakeholder forum in the early drug development arena! Merit travel grants are available. ⏰Abstract submission deadline: 28 November 2023.
ow.ly/HsQL50PR0G4
@lillian_siu @ElenaGarralda @AnastasiosStat2
Anastasios Stathis retweeted
#ESMOTAT24: Shape the future of cancer #drugdevelopment and take part in this unique forum gathering all relevant stakeholders in #oncology. ⏰Abstract submission deadline: 28 November 2023.
ow.ly/HC3A50PLsEJ
@lillian_siu @ElenaGarralda @AnastasiosStat2
Anastasios Stathis retweeted
#ESMOTAT24 taking place Feb 26-28, 2024, in Paris! Abstract submission now open till Nov 28, 2023: esmo.org/meeting-calendar/es… @myESMO
New meeting features with parallel industry sessions - not to be missed
Anastasios Stathis retweeted
Dall’EOC cinque nuovi Professori titolari per la Facoltà di scienze biomediche dell’USI.
Comunicato stampa: eoc.ch/comunicazione/Comunic…
Anastasios Stathis retweeted
📢🗓The #17ICML Scientific Program, based on more than 800 submitted abstracts, is almost ready!
Watch the video to have a sneak peek of the 17-ICML and stay tuned!
Anastasios Stathis retweeted
The abstract of the other one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @SpexisAg
Adding CXCR4 inhibition to improve activity of anti-lymphoma agents:
abstractsonline.com/pp8/#!/1…
Anastasios Stathis retweeted
The abstract of one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @ManelEsteller
ERBB4 as resistance to BTK and PI3K inhibitors in lymphomas:
abstractsonline.com/pp8/#!/1…
Anastasios Stathis retweeted
Tat esmo paris the ladies congratulation for2023 and next years 2024,25,26 in paris
Anastasios Stathis retweeted
Even at 8 am 🌅 really important and interactive discussion about data integrity and AI at #ESMOTAT23 workshop with @myESMO #YOC !
Thank you @recnac1 and @rsnfehrmann for amazing talks and discussion!
@EMariamidze – at Paris, France
Anastasios Stathis retweeted
2022 MDICT recommendations discussed at #ESMOTAT23 highlight the need to rethink how research studies are conducted and for multi-stakeholder collaboration.
Full article available
📌ow.ly/oIwQ50NaxC8
@rdienstmann
Anastasios Stathis retweeted
#ESMOTAT23 opens tomorrow (6/3) bringing together communities developing the most promising new cancer drugs. Keep an eye on the hashtag for the latest news 🙂
ow.ly/a5bR50N7VQM
@lillian_siu @AnastasiosStat2 #epigenetics #immunotherapy #celltherapies #precisiononcology
Anastasios Stathis retweeted
.@myESMO & @AACR & @ESOncology joint conf on lymphoma (organised by @IOR_Bellinzona ). A complementary partnership ! Lymphoma has become complex and conf require oncol, haem but also translational/basic scientists & research Organisations. This is the future of conferences
Submit an abstract by March 15 for the 17th International Conference on Malignant Lymphoma (June 13-17; Lugano Switzerland), organized by @IOR_Bellinzona in cooperation with the AACR, @ESOncology, and @myESMO. Learn more:
bit.ly/3Ya146r
#17ICML
Anastasios Stathis retweeted
W/ a record-breaking no of abstracts submitted, #ESMOTAT23 promises to be the most exciting edition to date. Register now & connect w/ leaders from academia & industry developing the latest anticancer therapies. Deadline: 18/1
ow.ly/ITCu50Mqh1F
@lillian_siu @AnastasiosStat2